Support: 888-992-3836
Home
NewsWire
Subscriptions
Boards:
Quotes:
Login/Register
MAIN MENU
BOARDS
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
CRYPTO
Top Cryptocurrencies
Top Tokens
New Cryptocurrencies
Crypto Converter
HOT!
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
Poststream
My Stocks Activity
Ticker Buzz Cloud
NEWS
iHub Newswire
InvestorsHub Daily
Newsletters
All News
Recent News
News By Market
News Scanner
Price & News Alerts
MARKET DATA
Streamer
Level 2
Live Charts
Trades
Portfolio
Toplists
Economic Calendar
Follow Feed
Trader Alerts
Forex Prices
Commodities
Alerts
USER TOOLS
Favorites
Mailbox
My Image Gallery
Advanced Search
My Settings
Educational Channel
Upgrade Options
Mailbox
Favorites
Hot!
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
Poststream
My Stocks Activity
Ticker Buzz Cloud
Crypto
Top Cryptocurrencies
Top Tokens
New Cryptocurrencies
Crypto Converter
Market Data
Streamer
Level 2
Live Charts
Trades
Portfolio
Toplists
Economic Calendar
Follow Feed
Trader Alerts
Forex Prices
Commodities
Alerts
Level 2
Boards:
Quotes:
Login
Register
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
Hot!
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
My Stocks Activity
Ticker Buzz Cloud
Mailbox
Favorites
Market Data
Streamer
Level 2
Live Charts
Trades
Portfolio
Toplists
Economic Calendar
Follow Feed
Trader Alerts
Cannabis Stocks
Forex Prices
Commodities
Alerts
Crypto
Top Cryptocurrencies
Top Tokens
New Cryptocurrencies
Crypto Converter
News
iHub Newswire
InvestorsHub Daily
Newsletters
All News
Recent News
News By Market
News Scanner
Price & News Alerts
User Tools
Favorites
Mailbox
My Image Gallery
Advanced Search
My Settings
Educational Channel
Streamer
Level 2
Support: 888-992-3836
Copyright © 2022 InvestorsHub Inc.
DON'T MISS YOUR FREE DAILY BRIEFING!
Subscribe to our daily news briefing, partner offers and other newsletters catered to investors like you!
Stock Options
NEW to INVESTORSHUB
Home
Boards
US Listed
Biotechs
FATE
Fate Therapeutics Inc.
19
Follow
19
Quote
Board
Chart
Level 2
News
Trades
Options
New
Financials
Historical
More
News
Trades
Options
New
Financials
Historical
New Post
About
Popular
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
GO
Home
Boards
US Listed
Biotechs
FATE
Fate Therapeutics Inc.
19
Follow
19
Quote
Board
Chart
Level 2
News
Trades
Options
New
Financials
Historical
More
News
Trades
Options
New
Financials
Historical
New Post
About
Popular
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
GO
Likes
Subject
Older
(OT): InnDura Therapeutics is a preclinical stage company,
jondoeuk
06/01/23 1:14 PM
(OT): The latest license is to Replay Bio
jondoeuk
06/01/23 1:09 PM
Could be high TIL. I know MRK's Keytruda
jondoeuk
06/01/23 1:05 PM
If NKX101 is successful, it would establish proof-of-concept,
jondoeuk
06/01/23 1:01 PM
GMO is no match to organic NK.
NY1972
05/29/23 10:28 AM
Why NKTX is not targeting cervical cancer?
NY1972
05/27/23 6:03 PM
Why endometrial cancer? High TIL + high NK?
NY1972
05/27/23 5:58 PM
Encouraging data that caused the stock to rise
jondoeuk
05/27/23 5:19 PM
All these GMO cells is no match to
NY1972
05/26/23 8:44 AM
''G-NK cells are associated with improved OS and
jondoeuk
05/25/23 5:45 PM
Will load 4.70’ s again
harry crumb
05/20/23 11:47 PM
(OT) Indapta Therapeutics announces FDA clearance of an
jondoeuk
05/17/23 12:33 PM
Will load the 4.70 area again
harry crumb
05/16/23 4:48 PM
It will be interesting to see the design
jondoeuk
05/16/23 2:32 PM
Speaking of GD2 https://www.nature.com/articles/s41591-023-02363-y
jondoeuk
05/15/23 6:49 PM
CGEM MICA/B good enough for a poster. So
NY1972
05/11/23 10:34 PM
No, but with NKs you can have a
jondoeuk
05/11/23 6:49 PM
A number won't, but both FATE (I'm negative
jondoeuk
05/05/23 2:12 PM
Looking at 250 mil burn, FATE and other
NY1972
05/03/23 11:34 PM
AFM28 - ADCP.
NY1972
04/27/23 12:11 PM
Some CEOs won't even PR. AFMD was a
NY1972
04/26/23 9:29 PM
A letter (dated April 4th) was received saying
jondoeuk
04/25/23 11:50 PM
It has advantages as multiple edits can result
jondoeuk
04/25/23 11:10 PM
If you listen to DTIL CSO who just
NY1972
04/22/23 3:21 PM
TME is poorly understood. Mgt. is crossing a
NY1972
04/22/23 3:17 PM
Clearly active (I wonder if they plan to
jondoeuk
04/21/23 9:13 PM
An IIT (in China) testing this (using the
jondoeuk
04/21/23 9:06 PM
Depends on the edits. The authors go on
jondoeuk
04/21/23 9:01 PM
Endless edits still doesn't address the infection that
NY1972
04/20/23 1:49 PM
What is the impact of multiple edits on
NY1972
04/19/23 8:33 PM
Some more info on CLASH https://www.liebertpub.com/doi/10.1089/crispr.2023.0003
jondoeuk
04/19/23 7:13 PM
The poster
jondoeuk
04/19/23 3:34 PM
I was hoping they would have focused on
jondoeuk
04/19/23 3:30 PM
Out 6.60-6.65, $$$$$
harry crumb
04/18/23 3:08 PM
ICE that does ADCP has value. AFM 13
NY1972
04/16/23 8:10 PM
CAR NK looks like CART. What is the
NY1972
04/13/23 10:04 AM
I can see why they chose the targets
jondoeuk
04/11/23 4:07 PM
In this, the authors show that iPSC-derived NKs
jondoeuk
04/05/23 5:59 PM
From twitter https://twitter.com/brendan_49/status/1636044757360164875
jondoeuk
03/17/23 3:17 PM
(OT) Cellinfinity Bio will leverage proprietary, directed evolution,
jondoeuk
03/15/23 8:09 PM
Preclinical data on an anti-CXCR5 CAR https://www.nature.com/articles/s41467-020
jondoeuk
03/15/23 7:51 PM
Naturally, HLA-G blocks immune cell function by binding
jondoeuk
03/15/23 6:53 PM
(OT) CARTemis Therapeutics
jondoeuk
03/15/23 6:36 PM
Have you seen this in gene modified NK
NY1972
03/15/23 3:27 PM
CAT-248, an allogeneic CD70-directed CAR-NK cell therapy effectively
jondoeuk
03/14/23 10:08 PM
(OT) Catamaran Bio will use healthy donor NK
jondoeuk
03/14/23 10:06 PM
Engineered iPSC-derived NK cells as next-generation immunotherapies for
jondoeuk
03/14/23 9:44 PM
Identification of novel CAR transmembrane and endodomains for
jondoeuk
03/14/23 9:41 PM
In this at 5.00 awhile back
harry crumb
03/01/23 8:31 AM
Whats the story behind these lawsuits? Any thoughts
harry crumb
02/17/23 11:15 PM
Likes
Subject
Older
Latest Posts
Older
jondoeuk
06/01/23 1:14 PM
(OT): InnDura Therapeutics is a preclinical stage company,
jondoeuk
06/01/23 1:09 PM
(OT): The latest license is to Replay Bio
jondoeuk
06/01/23 1:05 PM
Could be high TIL. I know MRK's Keytruda
jondoeuk
06/01/23 1:01 PM
If NKX101 is successful, it would establish proof-of-concept,
NY1972
05/29/23 10:28 AM
GMO is no match to organic NK.
NY1972
05/27/23 6:03 PM
Why NKTX is not targeting cervical cancer?
NY1972
05/27/23 5:58 PM
Why endometrial cancer? High TIL + high NK?
jondoeuk
05/27/23 5:19 PM
Encouraging data that caused the stock to rise
NY1972
05/26/23 8:44 AM
All these GMO cells is no match to
jondoeuk
05/25/23 5:45 PM
''G-NK cells are associated with improved OS and
harry crumb
05/20/23 11:47 PM
Will load 4.70’ s again
jondoeuk
05/17/23 12:33 PM
(OT) Indapta Therapeutics announces FDA clearance of an
harry crumb
05/16/23 4:48 PM
Will load the 4.70 area again
jondoeuk
05/16/23 2:32 PM
It will be interesting to see the design
jondoeuk
05/15/23 6:49 PM
Speaking of GD2 https://www.nature.com/articles/s41591-023-02363-y
NY1972
05/11/23 10:34 PM
CGEM MICA/B good enough for a poster. So
jondoeuk
05/11/23 6:49 PM
No, but with NKs you can have a
jondoeuk
05/05/23 2:12 PM
A number won't, but both FATE (I'm negative
NY1972
05/03/23 11:34 PM
Looking at 250 mil burn, FATE and other
NY1972
04/27/23 12:11 PM
AFM28 - ADCP.
NY1972
04/26/23 9:29 PM
Some CEOs won't even PR. AFMD was a
jondoeuk
04/25/23 11:50 PM
A letter (dated April 4th) was received saying
jondoeuk
04/25/23 11:10 PM
It has advantages as multiple edits can result
NY1972
04/22/23 3:21 PM
If you listen to DTIL CSO who just
NY1972
04/22/23 3:17 PM
TME is poorly understood. Mgt. is crossing a
jondoeuk
04/21/23 9:13 PM
Clearly active (I wonder if they plan to
jondoeuk
04/21/23 9:06 PM
An IIT (in China) testing this (using the
jondoeuk
04/21/23 9:01 PM
Depends on the edits. The authors go on
NY1972
04/20/23 1:49 PM
Endless edits still doesn't address the infection that
NY1972
04/19/23 8:33 PM
What is the impact of multiple edits on
jondoeuk
04/19/23 7:13 PM
Some more info on CLASH https://www.liebertpub.com/doi/10.1089/crispr.2023.0003
jondoeuk
04/19/23 3:34 PM
The poster
jondoeuk
04/19/23 3:30 PM
I was hoping they would have focused on
harry crumb
04/18/23 3:08 PM
Out 6.60-6.65, $$$$$
NY1972
04/16/23 8:10 PM
ICE that does ADCP has value. AFM 13
NY1972
04/13/23 10:04 AM
CAR NK looks like CART. What is the
jondoeuk
04/11/23 4:07 PM
I can see why they chose the targets
jondoeuk
04/05/23 5:59 PM
In this, the authors show that iPSC-derived NKs
jondoeuk
03/17/23 3:17 PM
From twitter https://twitter.com/brendan_49/status/1636044757360164875
jondoeuk
03/15/23 8:09 PM
(OT) Cellinfinity Bio will leverage proprietary, directed evolution,
jondoeuk
03/15/23 7:51 PM
Preclinical data on an anti-CXCR5 CAR https://www.nature.com/articles/s41467-020
jondoeuk
03/15/23 6:53 PM
Naturally, HLA-G blocks immune cell function by binding
jondoeuk
03/15/23 6:36 PM
(OT) CARTemis Therapeutics
NY1972
03/15/23 3:27 PM
Have you seen this in gene modified NK
jondoeuk
03/14/23 10:08 PM
CAT-248, an allogeneic CD70-directed CAR-NK cell therapy effectively
jondoeuk
03/14/23 10:06 PM
(OT) Catamaran Bio will use healthy donor NK
jondoeuk
03/14/23 9:44 PM
Engineered iPSC-derived NK cells as next-generation immunotherapies for
jondoeuk
03/14/23 9:41 PM
Identification of novel CAR transmembrane and endodomains for
harry crumb
03/01/23 8:31 AM
In this at 5.00 awhile back
harry crumb
02/17/23 11:15 PM
Whats the story behind these lawsuits? Any thoughts
Older
Fate Therapeutics Inc. (FATE)
Followers
19
Posters
37
Posts
(Today)
0
Posts
(Total)
289
Created
10/30/13
Type
Free
Moderators
jondoeuk
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
GO
Moderators' Board Intro has not been added
Most Liked Posts
(Last 30 Days)
No Liked Posts in the last 30 Days
Home
Boards
US Listed
Biotechs
Fate Therapeutics Inc. (FATE)
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
1D
1M
3M
6M
1Y
5Y
FATE Latest News
Fate Therapeutics to Present at Upcoming June Investor Conferences
05/31/2023 08:00:00 AM
Quarterly Report (10-q)
05/03/2023 04:11:36 PM
Current Report Filing (8-k)
05/03/2023 04:07:34 PM
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
05/03/2023 04:01:00 PM
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results
04/24/2023 08:00:00 AM
Most Liked Posts
(Last 30 Days)
No Liked Posts in the last 30 Days
New Post
Add FATE Alert
×
Add Price Alert
Add News Alert
Follow FATE
×
Add to Favorites
Follow
Shortcuts
Streamer
Follow Feed List
You must be logged in to give a plus1 award.